(Press-News.org) PHILADELPHIA (June 2, 2011) -- Although bitterness can sometimes be desirable – such as in the taste of coffee or chocolate – more often bitter taste causes rejection that can interfere with food selection, nutrition and therapeutic compliance. This is especially true for children. Now, scientists from the Monell Center and Integral Molecular describe the discovery of a compound that inhibits bitterness by acting directly on a subset of bitter taste receptors.
"Bitter taste is a major problem for pediatric drug compliance and also for proper nutrition, such as eating those healthy but bitter green vegetables," said Monell senior author Paul Breslin, Ph.D., a sensory biologist. "But we currently have very limited ways to effectively control bitter taste."
Bitterness is detected by a family of approximately 25 different taste receptors called TAS2Rs. Together, the TAS2Rs respond to a broad array of structurally different compounds, many of which are found in nature and can be toxic.
Discovery of bitter blockers would help scientists understand the signaling mechanisms of these receptors and promote the design of novel and more effective blockers.
Monell and Integral Molecular are collaborating on a large project to understand the structure and function of TAS2Rs. In a serendipitous discovery, the researchers found that probenecid, a molecule frequently used in receptor assays, is an inhibitor of a subset of bitter taste receptors. Probenecid also is an FDA-approved therapeutic for gout.
In the study, published in PLoS ONE, a series of in vitro studies revealed that probenecid does not physically block interaction of bitter molecules with the receptor's primary binding site. Rather, it appears to bind elsewhere on the receptor to modulate the receptor's ability to interact with the bitter molecule.
"Probenecid's mechanism of action makes it a useful tool for understanding how bitter receptors function," said Integral Molecular senior author Joseph B. Rucker, Ph.D. "This knowledge will help us develop more potent bitter taste inhibitors."
A series of human sensory studies established that probenecid robustly inhibited the bitter taste of salicin, a compound that stimulates one of the target receptors.
"This demonstrates how we can take in vitro experiments and go on to show how they make a difference functionally and perceptually," said Breslin.
Additional studies will continue to explore the structure and function of TAS2Rs. The overall goal is to identify the regions of the receptors that contribute to bitter molecule binding and how binding events lead to signaling events within the cell.
Understanding modulation of bitter receptor function may have additional implications for the respiratory and gastrointestinal systems, as bitter taste receptors also are expressed in the nose, the lungs and the intestines.
INFORMATION:
Also contributing to the research were first author Tiffani A. Greene, Anu Thomas, Eli Berdougo, and Benjamin J. Doranz of Integral Molecular, and Suzanne Alarcon of Rutgers University School of Environmental and Biological Sciences. Dr. Breslin is also faculty at Rutgers University School of Environmental and Biological Sciences. The research was funded by the National Institute on Deafness and Other Communication Disorders.
The Monell Chemical Senses Center is an independent nonprofit basic research institute based in Philadelphia, Pennsylvania. Monell advances scientific understanding of the mechanisms and functions of taste and smell to benefit human health and well-being. Using an interdisciplinary approach, scientists collaborate in the programmatic areas of sensation and perception; neuroscience and molecular biology; environmental and occupational health; nutrition and appetite; health and well-being; development, aging and regeneration; and chemical ecology and communication. For more information about Monell, visit www.monell.org.
Integral Molecular is a biotechnology company committed to providing innovative solutions for scientific research and drug discovery applications involving integral membrane proteins. Integral Molecular is a privately-owned company founded in 2001 and located in central Philadelphia. The company has been working with pharmaceutical, biotechnology and academic customers and collaborators since its inception, providing membrane protein related products and services that advance its customers' scientific objectives. For more information about Integral Molecular, visit www.integralmolecular.com.
END
The Federal Trade Commission recently held a seminar entitled "Debt Collection 2.0" and among the usual discussions of debt collection was a new topic: "Using Social Media for Debt Collection: Consumer Information, Collector Communications, and Privacy Issues."
Using social media, like Facebook and Twitter for debt collection purposes is something new. Joel Winston of the FTC told MSNBC, "We have received a few complaints about collectors who are using social media to either impersonate the person's friends or otherwise use it for harassment."
Social ...
The oral antifungal drug itraconazole, most commonly used to treat nail fungus, may keep prostate cancer from worsening and delay the need for chemotherapy in men with advanced disease. Details of the finding, from a clinical trial led by Johns Hopkins experts, are scheduled for presentation on Saturday, June 4 at the 2011 American Society of Clinical Oncology (ASCO) annual meeting (abstract #4532).
Currently, the drug is approved to treat fungal infections in nails and other organs. Serious side effects can include heart failure, and Johns Hopkins experts caution that ...
A study in a special early online publication of Cell, a Cell Press publication, reveals a promising new slow-release compound that protects mice against the neurodegenerative effects of both Huntington's and Alzheimer's disease. The 'prodrug' known only as JM6 works through a pathway involved in the breakdown of the amino acid tryptophan.
Surprisingly, JM6 delivers those benefits even though it doesn't cross the blood-brain barrier and therefore cannot act directly on the brain.
"Most would have assumed that the drug would have to enter the brain to have an effect," ...
Thousands of events are scheduled across the nation to celebrate the joys and traditions that come with riding bicycles. While most events are geared to welcome spring and summertime activities, some, like the Bike Bonanza in downtown Salt Lake City, promote healthy living and efficiency. Another national event, the Ride of Silence, is dedicated to reminding people about bicycle safety and honoring those killed in bicycle accidents.
Each year since 2003, riders have gathered on the third Wednesday of May to bring awareness to the hazards bicyclists endure from motorists. ...
AUDIO:
University of Michigan School of Public Health researcher Stoddard's research shows a link between violent behavior and brain injury in youth.
Click here for more information.
ANN ARBOR, Mich.---Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health.
Further, the research found that young people who suffered a recent ...
(SALT LAKE CITY)—Parents and health care providers can't always tell whether toddlers display signs of autism syndrome disorder (ASD), but new research from the University of Utah shows that a significant portion of at-risk children between 14-24 months can be identified through systematic screening by autism experts and providers working together.
Identifying children with ASD as young as possible is critical for the early intervention that can improve their lives and ability to function in the world. But a systematic way to do that has not been established, according ...
As the World Health Organisation suggests the E. coli outbreak in Germany is a strain never before seen in an outbreak – O104:H4 – laboratory science conducted at the University of Southampton indicates a role for copper in preventing the spread of such infections.
Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, explains: "A study looking at copper's efficacy against new strains of E. coli has just been completed. Although it did not specifically look at O104, all the strains investigated ...
LOUISVILLE, Ky. – University of Louisville researchers are one step closer to helping millions of people whose salivary glands no longer work because of disease or damage from treatment of diseases.
The scientific finding of Douglas Darling, PhD, professor, Department of Oral Health and Rehabilitation, UofL School of Dentistry, and his team identified a protein sorting mechanism used by the salivary gland. The National Institutes of Health supported study published on-line first this week in the Journal of Dental Research.
The scientific discovery could form the ...
Scientists from the Florida campus of The Scripps Research Institute have uncovered a potentially important new therapeutic target that could prevent stress-related cell death, a characteristic of neurodegenerative diseases such as Parkinson's, as well as heart attack and stroke.
In the study, published recently in the journal ACS Chemical Biology, the scientists showed they could disrupt a specific interaction of a critical enzyme that would prevent cell death without harming other important enzyme functions.
The enzyme in question is c-jun-N-terminal kinase (JNK), ...
Wrong-site surgery is a one of the most preventable forms of medical malpractice because it is so unnecessary. It indicates sloppiness in procedure and a level of inattention to detail you would hope to never find in a surgeon or their staff.
While there are often explanations, there is never any excuse. It might be excusable in an emergency military hospital, with surgeons operating under a crush of battle injured patients, but it should simply never occur in a modern hospital.
A statement from the website of the American Academy of Orthopaedic Surgeons notes: "Wrong-site ...
